Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 73-82

  Nakamura, Masataka ^a   Oda, Shigeto ^a   Sadahiro, Tomohito ^a   Hirayama, Yoh ^a   Watanabe, Eizo ^a   Tateishi, Yoshihisa ^a   Nakada, Taka Aki ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; POLY(METHYL METHACRYLATE); TUMOR NECROSIS FACTOR ALPHA;

ARTIFICIAL MEMBRANE; BLOOD; HEMODIAFILTRATION; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK;

CYTOKINES; HEMODIAFILTRATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MEMBRANES, ARTIFICIAL; POLYMETHYL METHACRYLATE; SEPSIS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954919023     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314855     Document Type: Article

References (30)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
3. Volk HD, Reinke P, Döcke WD: Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 2000;74:162-177.
4. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d'Intini V, Bellomo R: Interpreting the mechanism of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003;27:792-801.
5. Webster NR, Galley HF: Immunomodulation in the critically ill. Br J Anaesth 2009;103:70-81.
6. Cinel I, Opal SM: Molecular biology of inflammation and sepsis: a primer. Crit Care Med 2009;37:291-304.
7. De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-853.
8. Sieberth HG, Kierdorf HP: Is cytokine removal by continuous hemofiltration feasible? Kidney Int Suppl 1999;72: S79-S83.
9. Honore PM, Joannes-Boyau O, Boer W, Collin V: High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif 2009;28:1-11.
10. Haase M, Bellomo R, Morgera S, Baldwin I, Boyce N: High cut-off point membranes in septic acute renal failure: systematic review. Int J Artif Organs 2007;30:1031-1041.
11. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K: Current topics on cytokine removal technologies. Ther Apher 2001;5:306-314.
12. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M: Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher 2002;6:193-198.
13. Hirasawa H, Oda S, Matsuda K: Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib Nephrol 2007;156:365-370
14. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M: Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005;29:169-175.
15. Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R, Hirasawa H: Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med 2008;14:257-263.
16. Shimizu T, Endo Y, Tsuchihashi H, Akabori H, Yamamoto H, Tani T: Endotoxin apheresis for sepsis. Transfus Apher Sci 2006;35:271-282.
17. Hirasawa H, Oda S, Shiga H, Matsuda K, Nakanishi K: Endotoxin adsorption or hemodiafiltration in the treatment of multiple organ failure. Curr Opin Crit Care 2000;6:421-425.
18. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
19. Piccinni P, Dan M, Carraro R, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D'Intini V, Tetta C, Bellomo R, Ronco C: Early isovolemic haemofiltration in oligouric patients with septic shock. Intensive Care Med 2006;32:80-86.
20. Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G, Hernandez G: Highvolume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006;32:713-722.
21. Bousskey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, Georges H, Leroy O: A pilot study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008;34:1646-1653.
22. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-405.
23. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S: Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006;10:12-18.
24. Nakamura T, Sugaya T, Koide H: Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion. Shock 2009;31:454-459.
25. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-2452.
26. Hirano T, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, Nakamura M, Asai T, Kitamura N: Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration. Blood Purif 2004;22:188-197.
27. Schefold JC, Haehling S, Corsepius M, Pohle C, Kruschke P, Zuckermann H, Volk HD, Reinke P: A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complementactivating product 5A. Shock 2007;28:418-425.
28. Schefold JC, Hasper D, Jorres A: Organ crosstalk in critically ill patients: hemofiltration and immunomodulation in sepsis. Blood Purif 2009;28:116-123.
29. Watanabe E, Hirasawa H, Oda S, Matsuda K, Hatano M, Tokuhisa T: Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor-and interleukin-1-related gene polymorphisms. Crit Care Med 2005;33:89-97.
30. Smith A, Lamagni TL, Oliver I, Efstratiou A, George RC, Stuart JM: Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? Lancet Infect Dis 2005;5:494-500.